Arachidonoyl serotonin (AA-5-HT) modulates general fear-like behavior and inhibits mesolimbic dopamine release

@article{Freels2019ArachidonoylS,
  title={Arachidonoyl serotonin (AA-5-HT) modulates general fear-like behavior and inhibits mesolimbic dopamine release},
  author={Timothy G. Freels and Deranda B. Lester and Melloni N. Cook},
  journal={Behavioural Brain Research},
  year={2019},
  volume={362},
  pages={140-151}
}

Figures from this paper

Chronic Effects of Indirect and Direct Cannabinoid Receptor Agonists on Addiction-Related Behaviors and Dopamine Release
TLDR
Overall, neither AA-5-HT nor ACEA induced behavioral or neurochemical changes associated with abuse liability; however, indirect mechanisms of agonizing the cannabinoid system may be a better alternative than direct mechanisms if concerned with disrupting dopamine function.
TRPV1 blockers as potential new treatments for psychiatric disorders
TLDR
Preclinical studies yield favorable results with TRPV1 blockers in animal models of psychiatric disorders, and compounds blocking both TRpV1 and the anandamide-hydrolyzing enzyme, fatty acid amide hydrolase (FAAH), termed dual TRPv1/FAAh blockers, have been investigated with promising results.
Impact of Cannabinoid Type 1 Receptor Modulation on Risky Decision-Making
TLDR
It is suggested that CB1R activation expedites engagement in punishment based risk- taking without affecting overall preference for risky vs. safe options, which indicates that risk preference and rate of deliberation for risk-taking are influenced by distinct neural substrates.
Cerebellar Modulation of Mesolimbic Dopamine Transmission Is Functionally Asymmetrical
TLDR
It is suggested that cerebellar output can modulate mesolimbic dopamine transmission, and this modulation contributes to asymmetrically lateralized dopamine release.
Cerebellar Modulation of Mesolimbic Dopamine Transmission is Functionally Asymmetrical
TLDR
It is suggested that cerebellar output can modulate mesolimbic dopamine transmission, and this modulation contributes to asymmetrically lateralized dopamine release.
Risky decision-making predicts dopamine release dynamics in nucleus accumbens shell
TLDR
In vivo fixed potential amperometry in male Long-Evans rats observed a positive correlation between medial forebrain bundle-evoked dopamine release in the NACs and risky decision-making, suggesting that risk-taking is associated with elevated dopamine sensitivity.
Risky Decision-Making Predicts Dopamine Release Dynamics in Nucleus Accumbens Shell
TLDR
Excessive risky decision-making is a hallmark of addiction, promoting ongoing drug seeking despite the risk of social, financial, and physical consequences, and phasic NACs dopamine release is identified as a possible therapeutic target for alleviating the excessive risk-taking observed across multiple forms of psychopathology.
Miniature FSCV Devices: A Review
TLDR
The emerging miniature FSCV devices that have integrated on-board data processing capabilities to mitigate external data processing are discussed and can accelerate neurochemistry research, reducing time spent analysing data on external computers, and allowing for investigation into questions on neurotransmitter dynamics in target brain regions.
...
1
2
...

References

SHOWING 1-10 OF 101 REFERENCES
Anxiolytic Effects in Mice of a Dual Blocker of Fatty Acid Amide Hydrolase and Transient Receptor Potential Vanilloid Type-1 Channels
TLDR
Simultaneous ‘indirect’ activation of CB1 receptors following FAAH inhibition, and antagonism at TRPV1 receptors might represent a new therapeutic strategy against anxiety.
Endocannabinoid System and TRPV1 Receptors in the Dorsal Hippocampus of the Rats Modulate Anxiety-like Behaviors
TLDR
It seems that TRPV1 receptors are not involved in the effects of anandamide on anxiety-related behaviors in the CA1 region, and both endocannabinoid system and TRP V1 receptors may affect anxiety-like behaviors.
Opposing Roles for Cannabinoid Receptor Type-1 (CB1) and Transient Receptor Potential Vanilloid Type-1 Channel (TRPV1) on the Modulation of Panic-Like Responses in Rats
TLDR
Evidence is provided that an endogenous substance, possibly anandamide, may exert both panicolytic and panicogenic effects via its actions at CB1 receptors and TRPV1 channels, respectively, which might be exploited for the pharmacotherapy of panic attacks and anxiety-related disorders.
Anxiolytic-like effect induced by the cannabinoid CB1 receptor agonist, arachydonilcyclopropylamide (ACPA), in the rat amygdala is mediated through the D1 and D2 dopaminergic systems
TLDR
It can be concluded that the dopaminergic system of the amygdala may be involved, at least partly, in the anxiolytic-like effects induced by ACPA in the rat amygdala.
...
1
2
3
4
5
...